| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Halladay Benjamin | Chief Financial Officer | C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR | /s/ Sheldon L. Koenig, by power of attorney | 18 Sep 2025 | 0001953943 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESPR | Common Stock | Sale | $19,785 | -7,046 | -1.5% | $2.81 | 474,862 | 17 Sep 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares were sold to satisfy tax obligation on vested shares of restricted stock units. |
| F2 | Includes 7,446 shares recently acquired in Esperion's Employee Stock Purchase Plan. |